Afuco™ Anti-Human TNFRSF6B ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TNFRSF6B ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The TR6 antibodies are used for the treatment of chronic and acute inflammation, arthritis, septicemia, autoimmune diseases, transplant rejection, graft vs. host disease, infection, stroke, ischemia, acute respiratory disease syndrome, restenosis, brain injury, AIDS, Bone diseases, cancer (such as lymphoproliferative disorders), atheroschlerosis, and Alzheimers disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-610CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TNFRSF6B |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |